Synthetic peptide selected from the N terminal region of Human OAZ1, conjugated to KLH (NP_004143).
Our Abpromise guarantee covers the use of ab85221 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB | 1/50 - 1/1000. Predicted molecular weight: 25 kDa. | |
Indirect ELISA | 1/1000. |
Blocking/Dilution buffer: 5% NFDM/TBST.
ab85221 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"